Share Name Share Symbol Market Type Share ISIN Share Description
AstraZeneca LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -113.00p -1.79% 6,204.00p 6,207.00p 6,208.00p 6,262.00p 6,079.00p 6,182.00p 3,547,183 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 16,632.7 1,648.8 175.5 33.6 78,580.70

AstraZeneca's Bevespi Aerosphere Gets EU Marketing Recommendation

19/10/2018 1:51pm

Dow Jones News

AstraZeneca (LSE:AZN)
Historical Stock Chart

1 Month : From Oct 2018 to Nov 2018

Click Here for more AstraZeneca Charts.
   By Adria Calatayud 

AstraZeneca PLC (AZN.LN) said Friday that the EU drug regulator's Committee for Medicinal Products for Human Use has recommended marketing authorization for Bevespi Aerosphere, an inhaler for treatment of chronic obstructive pulmonary disease.

The recommendation from the European Medicines Agency committee is based on the company's phase 3 pinnacle program, which demonstrated the efficacy and safety of the inhaler, the pharmaceutical company said.

Bevespi Aerosphere is approved in the U.S., Canada and Australia as a dual bronchodilator for the long-term maintenance treatment of chronic obstructive pulmonary disease, AstraZeneca said.

Shares at 1216 GMT were up 0.8% at 5,927 pence.


Write to Adria Calatayud at


(END) Dow Jones Newswires

October 19, 2018 08:36 ET (12:36 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

1 Year AstraZeneca Chart

1 Year AstraZeneca Chart

1 Month AstraZeneca Chart

1 Month AstraZeneca Chart
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:40 V:gb D:20181117 20:12:00